X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Lupin Ltd Fact Sheet, Lupin Ltd Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Lupin Ltd Fact Sheet   (LUPL)

Here is the latest financial fact sheet of Lupin Ltd. For more details, see the Lupin Ltd quarterly results and Lupin Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.

LUPIN Price History

Price Rs 722.3
Mkt Cap Rs m 325,835
Vol '000 70.8
P/E X 39.2
P/CF X 24.3
EPS (TTM) Rs 18.4
% ch % 0.4
No. of shares m 451.14
% ch week % -1.0
% ch 1-mth % -10.7
% ch 12-mth % -19.6
52 week H/L Rs 986.0/705.2
(As on Jun 14, 2019 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

LUPIN Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
LUPIN EQUITY SHARE DATA
High Rs1,0032,0372,1271,7501,465 
Low Rs6069041,2941,384727 
Sales per share (Unadj.) Rs251.7280.3316.4387.4349.6 
Earnings per share (Unadj.) Rs41.053.550.256.65.6 
Diluted earnings per shareRs40.753.350.156.75.6 
Cash flow per share (Unadj.) Rs46.863.161.076.829.6 
Dividends per share (Unadj.) Rs6.007.507.507.505.00 
Adj. dividends per shareRs5.967.477.497.515.01 
Dividend yield (eoy) %0.70.50.40.50.5 
Book value per share (Unadj.) Rs154.6204.1247.8298.9300.3 
Adj. book value per shareRs153.6203.3247.4299.2301.0 
Shares outstanding (eoy) m448.38449.49450.58451.58452.08 
Bonus/Rights/Conversions  ESOPESOP-ESOPSESOPS 
Price / Sales ratio x3.25.25.44.03.1 
Avg P/E ratio x19.627.534.127.7197.2 
P/CF ratio (eoy) x17.223.328.020.437.1 
Price / Book Value ratio x5.27.26.95.23.6 
Dividend payout %14.614.014.913.290.0 
Avg Mkt Cap Rs m360,767660,975770,740707,513495,502 
No. of employees `000NA14.216.416.817.0 
Total wages/salary Rs m14,64717,47321,41628,49528,647 
Avg. sales/employee Rs ThNM8,874.38,718.510,418.39,273.6 
Avg. wages/employee Rs ThNM1,230.71,309.81,697.01,681.0 
Avg. net profit/employee Rs ThNM1,692.71,382.61,523.0147.4 
LUPIN INCOME DATA
Net Sales Rs m112,866125,997142,555174,943158,042 
Other income Rs m1,1652,3981,8521,0651,504 
Total revenues Rs m114,031128,395144,407176,008159,545 
Gross profit Rs m30,02836,19636,85444,93131,475 
Depreciation Rs m2,6104,3474,8719,12210,859 
Interest Rs m267985951,5252,044 
Profit before tax Rs m28,31734,14833,23935,34920,076 
Minority Interest Rs m-331-412-88-72-71 
Prior Period Items Rs m00498335 
Extraordinary Inc (Exp) Rs m0000-14,644 
Tax Rs m9,6229,70410,5939,7852,885 
Profit after tax Rs m18,36424,03222,60725,5752,513 
Gross profit margin %26.628.725.925.719.9 
Effective tax rate %34.028.431.927.714.4 
Net profit margin %16.319.115.914.61.6 
LUPIN BALANCE SHEET DATA
Current assets Rs m61,00578,04098,874119,529122,095 
Current liabilities Rs m26,29634,63350,61261,20650,956 
Net working cap to sales %30.834.533.933.345.0 
Current ratio x2.32.32.02.02.4 
Inventory Days Days6973847685 
Debtors Days Days807711690120 
Net fixed assets Rs m30,01949,213114,194131,660129,876 
Share capital Rs m897899901903904 
"Free" reserves Rs m67,92290,833110,733134,073134,866 
Net worth Rs m69,31691,732111,634134,976135,771 
Long term debt Rs m1,5101,01853,73956,47864,245 
Total assets Rs m102,060132,610226,249266,073263,054 
Interest coverage x107.3349.156.924.210.8 
Debt to equity ratio x000.50.40.5 
Sales to assets ratio x1.11.00.60.70.6 
Return on assets %18.318.210.310.21.7 
Return on equity %26.526.220.318.91.9 
Return on capital %39.936.520.419.33.7 
Exports to sales %50.746.447.200 
Imports to sales %8.68.87.200 
Exports (fob) Rs m57,17758,48267,24400 
Imports (cif) Rs m9,65411,05710,19900 
Fx inflow Rs m63,07662,59371,40581,88553,141 
Fx outflow Rs m16,48016,59217,80721,50619,335 
Net fx Rs m46,59646,00153,59860,37833,807 
LUPIN CASH FLOW
From Operations Rs m 20,039 27,331 -3,824 41,135 17,512 
From Investments Rs m -8,585 -10,545 -69,617 -25,274 -14,073 
From Financial Activity Rs m -8,571 -1,969 58,364 4,332 -14,921 
Net Cashflow Rs m 2,883 14,817 -15,077 20,193 -11,482 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 46.6%
Foreign collaborators 0.2%
Indian inst/Mut Fund 11.3%
FIIs 31.9%
ADR/GDR 0.0%
Free float 10.1%
Shareholders 98,259
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 159, C.S.T. Road, Kalina, Santacruz (E), Mumbai - 400 098
E-MAIL rajvardhansatam@lupinpharma.com WEB www.lupinworld.com
TELEPHONE (022) 6640 2323 FAX (022) 2652 8806
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT In-house
AUDITOR Deloitte Haskins & Sells
CHM: D. B. Gupta COMP SEC: R. V. Satam YEAR OF INC: 1983 BSE CODE: 500257 FV (Rs): 2 DIV YIELD (%): 0.7

Read: LUPIN LTD 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   PLETHICO PHARMA  AUROBINDO PHARMA  VENUS REMEDIES  FDC LTD.  ASTRAZENECA PHARMA  

Compare LUPIN With:   PLETHICO PHARMA  AUROBINDO PHARMA  VENUS REMEDIES  FDC LTD.  ASTRAZENECA PHARMA  

Compare LUPIN With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Jet Airways and Yes Bank - What's Next for these Beaten Down Stocks?(Podcast)

Jet Airways and Yes Bank, both once market darlings are now being shunned by market participants. The National Stock Exchange (NSE) exchange notified that the shares of the airline.

Views on news

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

The Best 4 Small-cap Stocks to Buy(The 5 Minute Wrapup)

Jun 3, 2019

In the sometimes good sometimes bad market of small caps, there are strong buying opportunities available today. But this great opportunity won't last forever.

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

The Top 7 Stocks to Profit from Modi's Repeat Performance(Profit Hunter)

Jun 3, 2019

The long-term India story looks promising with the Modi government back in power. Which stocks are likely to go up the most?

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK LUPIN

MORE ON LUPIN

LUPIN - TEVA PHARMA COMPARISON

COMPARE LUPIN WITH

MARKET STATS